Alkermes Named a Top Place to Work by The Boston Globe
November 20 2017 - 7:00AM
Business Wire
–– Magazine Honors the Best Employers in
Massachusetts ––
–– Recognition Underscores Alkermes’ Commitment
to Creating a Positive Work Environment ––
Alkermes plc (NASDAQ: ALKS) today announced that it was named
one of The Boston Globe’s Top Places to Work. The Top Places to
Work recognition applauds the most admired workplaces in the state
based on anonymous employee feedback collected through a survey.
The survey measures employee opinions about their company’s
direction, execution, connection, management, work, pay and
benefits, and engagement.
“It is an honor to be recognized by The Boston Globe as one of
the Top Places to Work in Massachusetts. At Alkermes, our culture
embodies collaboration, respect for all, and an unwavering
commitment to and passion for our work,” said Madeline Coffin,
Senior Vice President of Human Resources at Alkermes. “We invest in
sustaining our culture, developing our employees, and building on
our total rewards program to attract the best possible people. We
are proud of our growth and performance as a company, but even more
proud of the people at the company who support the development and
delivery of new medicines to help address some of the most urgent
public health and mental illness challenges today.”
The rankings in the Top Places to Work are based on confidential
survey information collected by Energage (formerly
WorkplaceDynamics), an independent company specializing in employee
engagement and retention, from nearly 75,060 individuals at 334
organizations in Massachusetts. More than 500 Alkermes employees
participated in the survey. The employers were placed into one of
four groups based on number of employees: small, with 50 to 99;
medium, with 100 to 249; large, with 250 to 999; and largest, with
1,000 or more. Alkermes was ranked 31st within the “large company”
category. The winners share common traits, including offering
progressive benefits and incorporating employee voices throughout
company programs.
The complete list of the 2017 Top Places to Work winners can be
found at
http://www.bostonglobe.com/section/2017-top-places-to-work.
About AlkermesAlkermes plc
is a fully integrated, global biopharmaceutical company developing
innovative medicines for the treatment of central nervous system
(CNS) diseases. The company has a diversified commercial product
portfolio and a substantial clinical pipeline of product candidates
for chronic diseases that include schizophrenia, depression,
addiction and multiple sclerosis. Headquartered in Dublin, Ireland,
Alkermes plc has an R&D center in Waltham, Massachusetts; a
research and manufacturing facility in Athlone, Ireland; and a
manufacturing facility in Wilmington, Ohio. For more information,
please visit Alkermes’ website at www.alkermes.com.
About Boston Globe Media Partners
LLCBoston Globe Media Partners, LLC provides news and
information, entertainment, opinion and analysis through its
multimedia properties. BGMP includes the Boston Globe,
BostonGlobe.com, Boston.com, STAT and Globe Direct.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171120005306/en/
AlkermesFor Investors:Eva
Stroynowski, +1 781-609-6823orSandy Coombs, +1
781-609-6377orLindsey Smith, +1 781-609-6231
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Apr 2023 to Apr 2024